A new study conducted on 33,000 Swedish men with very low risk (stage I) prostate cancer indicates that close monitoring maybe a more viable option than immediate treatment. According to lead researcher Dr. Stacy Loeb, assistant professor in the departments of urology and population health at NYU Langone Perlmutter Cancer Center in New York, "there is no rush to get treatment...low-risk prostate cancer can be safely monitored...some men will eventually need treatment, but others will be able to preserve their quality of life for many years."
To read more about this study, click here.
No comments:
Post a Comment